Avaliação da hemorragia feto-materna em puérperas com indicação para ministração de imunoglobulina anti-D
This study evaluated fetomaternal hemorrhage (FMH) in 343 postpartum patients who required prophylaxis of Rh alloimmunization with anti-D immunoglobulin. The rosette test was applied to screen for patients needing quantitative determination of fetal blood transferred from the maternal circulation, w...
| Autores: | , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2005 |
| País: | Brasil |
| Recursos: | Fundação Oswaldo Cruz (FIOCRUZ) |
| Repositório: | Cadernos de Saúde Pública |
| Idioma: | português |
| OAI Identifier: | oai:ojs.teste-cadernos.ensp.fiocruz.br:article/2587 |
| Acesso em linha: | https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2587 |
| Access Level: | Acceso aberto |
| Palavra-chave: | Eritroblastose Fetal Transfusão Feto-materna Imunoglobina Rho(D) |
| Resumo: | This study evaluated fetomaternal hemorrhage (FMH) in 343 postpartum patients who required prophylaxis of Rh alloimmunization with anti-D immunoglobulin. The rosette test was applied to screen for patients needing quantitative determination of fetal blood transferred from the maternal circulation, which was then measured by the Kleihauer-Betke test (K-B). The rosette test was positive in 22 cases (6.4%). In five of these cases, K-B did not show fetomaternal hemorrhage (a 1.45% false-positive rate for the rosette test), and in one case the test was inconclusive. There were 8 cases with FMH < 10ml (2.3%), 6 cases with FMH from 10 to 30ml (1.7%), and two cases with FMH > 30ml (0.58%), requiring a supplementary dose of anti-D. The study concludes that following the rosette test, additional evaluation of FMH using a quantitative test was unnecessary in 93.6% of the cases. |
|---|